维生素K2与D3联合治疗对骨质疏松相关腰椎退变性疾病患者脊柱融合的影响
前瞻性非随机同期对照试验纳入接受TLIF或PLIF的骨量减少或骨质疏松患者,VK2+VD3组接受维生素K2、维生素D3和钙治疗,对照组仅接受钙和维生素D3。术后6个月VK2+VD3组完全融合率显著高于对照组(91.18% vs 71.43%,P=0.036),两组JOA-BPEQ和VAS评分术后均显著改善。
要点
- 术后6个月完全融合率VK2+VD3组91.18% vs 对照组71.43%(P=0.036)。
- 术后6个月VK2+VD3组骨密度升高且高于对照组,但无显著差异。
- 两组术后JOA-BPEQ和VAS评分均显著改善。
核心结论
- 给予维生素K2和维生素D3可提高腰椎椎间融合率、改善临床症状、促进骨信息并避免BMD进一步下降,观察期为TLIF或PLIF术后六个月内。
研究设计与样本
- 前瞻性非随机同期对照试验,纳入本科室接受TLIF或PLIF的骨量减少或骨质疏松患者,VK2+VD3组接受维生素K2、维生素D3和钙治疗,对照组仅接受钙和维生素D3。
- 共纳入78例患者,其中9例随后因2019-nCoV中止。
主要发现
- 术后6个月完全融合率VK2+VD3组91.18% vs 对照组71.43%(P=0.036)。
- 术后6个月VK2+VD3组骨密度升高且高于对照组,但无显著差异。
- 术后3个月VK2+VD3组I型前胶原氨基端前肽升高91.81%,C端末端肽降低8.06%。
- 两组术后JOA-BPEQ和VAS评分均显著改善。
局限性
- 证据等级为3级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A prospective and nonrandomized concurrent controlled trial. OBJECTIVE: To address the early effects of concurrent treatment with vitamin K2 and vitamin D3 on fusion rates in patients who have undergone spinal surgery. SUMMARY OF BACKGROUND DATA: Intervertebral pseudarthrosis has been reported after transforaminal lumbar interbody fusion (TLIF) or posterior lumbar interbody fusion (PLIF), especially in patients with osteopenia or osteoporosis. No study has assessed the early effects of concurrent treatment with vitamin K2 and vitamin D3 on fusion rates. METHODS: Patients with osteopenia or osteoporosis who underwent TLIF or PLIF in our department were included. Patients in the VK2+VD3 group received vitamin K2, vitamin D3, and calcium treatment, whereas subjects in the control group only received calcium and vitamin D3. Spine fusion was evaluated by computed tomography. The Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOA-BPEQ) and visual analog scale (VAS) were used to assess the clinical and neurological symptoms. Bone mineral density (BMD) and bone metabolism markers were measured for osteoporotic evaluation. RESULTS: Seventy-eight patients were included, and nine patients subsequently discontinued because of 2019-nCoV. At six months postoperatively, complete fusion rates were significantly higher in the VK2+VD3 group than that in the control group (91.18% vs 71.43%, P = 0.036). At six months postoperatively, BMD was increased in the VK2+VD3 group and was higher than that in the control group, although there was no significant difference. At three months postoperatively, a significant increase in procollagen type I amino terminal propeptide (91.81%) and a slight decrease in C-terminal end peptide (8.06%) were observed in the VK2+VD3 group. In both groups, the JOA-BPEQ and VAS scores were significantly improved after spine surgery. CONCLUSION: Administration of vitamin K2 and vitamin D3 can increase lumbar interbody fusion rates, improve clinical symptoms, promote bone information, and avoid further decline in BMD within six months after TLIF or PLIF.Level of Evidence: 3.
引用
- Zhang W, Li L, Zhou X, et al. Concurrent Treatment with Vitamin K2 and D3 on Spine Fusion in Patients with Osteoporosis-Associated Lumbar Degenerative Disorders. Spine (Phila Pa 1976). 2022. PMID: 34919073. doi:10.1097/BRS.0000000000004309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。